Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosis

PPF subtypes have significant differences in terms of prognosis and survival. The effect of AF drugs on progression varies, especially among radiological patterns. An individualized approach is required in the diagnosis, follow-up, and treatment of patients with PPF.

Authors

Institutions

Publication Details

Journal
Annals of Thoracic Medicine
Published
2025-03-31
DOI
https://doi.org/10.4103/atm.atm_213_24
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosis

Tuğçe Şahin Özdemirel, Fatih Üzer, Kerem Ensarıoğlu, Alper Ezircan et al.
Annals of Thoracic Medicine
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
article

Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosis

Tuğçe Şahin Özdemirel, Fatih Üzer, Kerem Ensarıoğlu, Alper Ezircan, Ahmet Ursavaş, Salim Mısırcı, Ismail Hanta, Berna Akıncı Özyürek, Esra Pancar Yüksel, Pelin Pinar Deniz, Funda Çoşkun, Bahadir Turkmen Arikan, Özlem Özdemir Kumbasar, İlknur Başyiğit, Nesrin Moğulkoç, Nesrin Öcal, Aykut Çilli
article en

Abstract

PPF subtypes have significant differences in terms of prognosis and survival. The effect of AF drugs on progression varies, especially among radiological patterns. An individualized approach is required in the diagnosis, follow-up, and treatment of patients with PPF.

Annals of Thoracic MedicineVol. 20(2)
Bursa Uludağ Üni̇versi̇tesi̇ (TR), Ankara University (TR), Akdeniz University (TR), Ege University (TR), Sağlık Bilimleri Üniversitesi (TR), Kocaeli Üniversitesi (TR), Cukurova University (TR)
Good health and well-being
Openalex Percentile: Top 90%
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosis — Tuğçe Şahin Özdemirel, Fatih Üzer, et al. · Annals of Thoracic Medicine (2025) | TGRS Research Map | TGRS